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Abstract
Background: Human genetic factors such as blood group antigens may affect the severity of infectious diseases. Presence
of specific ABO and Lewis blood group antigens has been shown previously to be associated with the risk of different
enteric infections. The aim of this study was to determine the relationship of the Lewis blood group antigens with
susceptibility to cholera, as well as severity of disease and immune responses to infection.
Methodology: We determined Lewis and ABO blood groups of a cohort of patients infected by Vibrio cholerae O1, their
household contacts, and healthy controls, and analyzed the risk of symptomatic infection, severity of disease if infected and
immune response following infection.
Principal Findings: We found that more individuals with cholera expressed the Le(a+b2) phenotype than the
asymptomatic household contacts (OR 1.91, 95% CI 1.03–3.56) or healthy controls (OR 1.90, 95% CI 1.13–3.21), as has
been seen previously for the risk of symptomatic ETEC infection. Le(a–b+) individuals were less susceptible to cholera and if
infected, required less intravenous fluid replacement in hospital, suggesting that this blood group may be associated with
protection against V. cholerae O1. Individuals with Le(a–b2) blood group phenotype who had symptomatic cholera had a
longer duration of diarrhea and required higher volumes of intravenous fluid replacement. In addition, individuals with
Le(a–b2) phenotype also had lessened plasma IgA responses to V. cholerae O1 lipopolysaccharide on day 7 after infection
compared to individuals in the other two Lewis blood group phenotypes.
Conclusion: Individuals with Lewis blood type Le(a+b2) are more susceptible and Le(a–b+) are less susceptible to V.
cholerae O1 associated symptomatic disease. Presence of this histo-blood group antigen may be included in evaluating the
risk for cholera in a population, as well as in vaccine efficacy studies, as is currently being done for the ABO blood group
antigens.
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Introduction
Cholera continues to cause severe diarrheal illness in people
with inadequate public health who live in resource-limited settings.
Cholera is endemic in countries in Asia and Africa, with new
outbreaks reported each year in several countries including, most
recently, in Zimbabwe and Haiti [1,2]. Vibrio cholerae O1 is the
predominant cause of endemic and epidemic cholera, and this
infection is the most common bacterial cause of acute watery
diarrhea in adults and children in Bangladesh [3]. There is a close
interplay between the organism and the human host in the disease
process, and understanding the nature of this interaction is
www.plosntds.org 1 December 2011 | Volume 5 | Issue 12 | e1413important for understanding pathophysiology, as well as for
designing the most appropriate preventive and therapeutic
strategies to reduce the morbidity and mortality associated with
this infection.
In previous studies, we have analyzed the genes expressed by V.
cholerae O1 during human infection [4,5,6], as well as the human
genes expressed in the gut mucosa in response to the infection [7].
These studies have suggested that human innate immune
responses are up-regulated in response to V. cholerae O1 infection,
and these innate immune responses may be important in
controlling the disease. Studies of protection from cholera in
exposed household contacts indicated that there is a genetic basis
for at least some portion of protection from infection [8,9], and a
candidate gene analysis in these contacts identified a polymor-
phism in the human gene for LPLUNC1, an innate immune
response gene, as linked to protection [10,11].
The other set of human genetic factors that have been studied in
relationship to susceptibility to enteric infections are the blood
group antigens. For cholera, blood group O has been associated
with a lower risk of colonization in exposed household contacts
[12] but if colonized, a higher risk of more severe disease
[12,13,14]. In contrast, blood groups AB or A have been shown to
be associated with more severe illness in individuals infected with a
related pathogen, enterotoxigenic Escherichia coli (ETEC), in
children in Bangladesh [15].
Another set of blood group antigens, the Lewis blood group
antigens Lewis a (Le
a) and Lewis b (Le
b), are carbohydrate
antigens related to the ABO blood group antigen that are
synthesized in epithelial tissues and adsorbed to the surface of red
blood cells [16]; these antigens can also be detected in saliva and
other secretions, as well as on cells of mucosal epithelia [17,18].
The Lewis antigen system has three different phenotypes;
Le(a+b2) (these individuals have the nonsecretor phenotype);
Le(a–b+), in which a fucosyltransferase converts Le
a to Le
b (these
individuals have the secretor phenotype); or Le(a–b2), in which
there is a failure to express either antigen (these individuals can be
either secretors or non-secretors) [19]. In a previous study of
ETEC diarrhea in Bangladesh, we showed that the approximate
proportions of these three phenotypes in the population were:
Le(a+b2) 26%; Le(a–b+) 58%; and Le(a–b2) 16% [20]. We also
showed that patients with the Le(a+b2) phenotype had an
increased risk of having symptomatic ETEC diarrhea compared to
the other two phenotypes, particularly if infected with an ETEC
strain expressing a CFA/I group colonization factor; this increased
risk of symptomatic disease was not seen in patients infected with
ETEC expressing other colonization factors, or with rotavirus.
Previous studies have suggested that the CFA/I group colonization
factors of ETEC bind the Le
a antigen on epithelial cells of the
small intestine [21]. Conversely, susceptibility to Helicobacter pylori
infection was higher in Le(a–b+) individuals [22]. In the present
study, we analyzed the relationship of Lewis blood group antigen
to the risk of symptomatic V. cholerae O1 infection in a cohort of
patients and their household contacts in Bangladesh, as well as the
relationship of Lewis antigen phenotype to severity of and immune
responses following disease.
Materials and Methods
Study population and sample collection
The study was carried out on patients with cholera presenting to
the icddr,b diarrheal disease hospital in Dhaka, Bangladesh.
Hospitalized patients with acute watery diarrhea were confirmed
by stool culture to be infected with V. cholerae O1 as previously
described and enrolled on the 2
nd day of hospitalization after
informed consent [8,23]. On the same day as patients were
enrolled in the study (defined as day 2), field workers enrolled all
consenting household contacts of each index patients, defined as
individuals who shared the same cooking pot as the index patient
for three or more days [23]. Index patients were assessed for other
clinical parameter. The type of dehydration status and recovery of
patients was assessed by experienced physicans in the icddr,b
diarrheal hospital [24]. Household contacts were followed
prospectively on study days 2–10, providing daily rectal swabs
for cultures for V. cholerae O1, as well as giving clinical histories for
diarrheal illness. Blood specimens were obtained from index
patients and household contacts on study days 2, 7 and 30. Saliva
specimens were collected from all participants on study day 2.
Saliva specimens were also obtained at one time point from 283
healthy individuals who were from an urban setting and in a
similar socio-economic status as the index patients, to determine
the distribution of the Lewis blood group antigens in the general
population. Blood and saliva samples obtained at day 2 were used
for the determination of the ABO and Lewis blood group
phenotypes, respectively. Blood samples at each time point were
assessed for vibriocidal antibody, and IgG and IgA antibodies
against cholera toxin B subunit (CTB) and lipopolysaccharide
(LPS) antigens.
Ethics statement
This study was conducted according to the principles expressed
in the declaration of Helsinki. We obtained written consent from
each individual prior to participation. Written informed consent
was obtained from adults participating in the study. This study was
approved by the Ethical and Research Review Committees of the
International Centre for Diarrhoeal Disease Research, Dhaka,
Bangladesh (icddr,b) and the Institutional Review Board of
Massachusetts General Hospital, Boston, MA.
Confirmation of bacterial strains
For all index cases, stool specimens were cultured on
taurocholate-tellurite gelatin agar (TTGA) plates for isolation of
V. cholerae. After overnight incubation of plates, specific monoclo-
Author Summary
Cholera remains a severe diarrheal disease, capable of
causing extensive outbreaks and high mortality. Blood
group is one of the genetic factors determining predispo-
sition to disease, including infectious diseases. Expression
of different Lewis or ABO blood group types has been
shown to be associated with risk of different enteric
infections. For example, individuals of blood group O have
a higher risk of severe illness due to V. cholerae compared
to those with non-blood group O antigens. In this study,
we have determined the relationship of the Lewis blood
group antigen phenotypes with the risk of symptomatic
cholera as well as the severity of disease and immune
responses following infection. We show that individuals
expressing the Le(a+b2) phenotype were more suscepti-
ble to symptomatic cholera, while Le(a–b+) expressing
individuals were less susceptible. Individuals with the Le(a–
b2) blood group had a longer duration of diarrhea when
infected, required more intravenous fluid replacement, and
had lower plasma IgA antibody responses to V. cholerae
LPS on day 7 following infection. We conclude that there is
an association between the Lewis blood group and the risk
of cholera, and that this risk may affect the outcome of
infection as well as possibly the efficacy of vaccination.
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and Inaba serotypes by slide agglutination test [25,26]. Rectal
swabs from household contacts were collected in Cary-Blair
transport media, taken to the icddr,b, and cultured on TTGA
followed by colony identification as above. Some specimens were
also enriched in alkaline peptone water for 4 hours prior to
culturing [3].
Blood group ABO typing
For ABO blood group typing, a slide agglutination test was
carried out according to the manufacturer’s instruction (Biotec
laboratories, UK).
Lewis blood group typing
Lewis blood group phenotype was determined using saliva
samples and a dot blot immunoassay procedure [20,27]. For this
purpose, 2 ml of saliva were applied to nitrocellulose membrane
strips and allowed to dry. After blocking with 1% bovine serum
albumin, mouse monoclonal anti-Le
a and anti-Le
b antibodies
(Abcam, Cambridge, UK) were added and the strips were
incubated for 30 min at room temperature with gentle shaking.
The strips were then washed and incubated with secondary,
horseradish peroxidase-conjugated antibody for another 30 min.
After washing, the strips were developed with 4-chloro-1-naphthol
and 3% hydrogen peroxide. A specimen was considered positive
when a dark black spot appeared on the membrane.
Immunological assays
Vibriocidal antibody assays were performed using guinea pig
complement and the homologous serotype of V. cholerae O1
isolated from the patient, either El Tor Ogawa (strain 25049) or El
Tor Inaba (strain T-19479) as previously described [28]. The
vibriocidal titer was defined as the reciprocal of the highest plasma
dilution resulting in .50% reduction of the optical density
compared to that of control wells without plasma. Seroconversion
was defined as a 4-fold or higher increase in vibriocidal titer after
infection. Plasma IgG and IgA antibodies specific to CTB and LPS
were measured by kinetic ELISA procedure as previously
described [29,30]. In brief, 96-well microtiter plates were coated
with either purified V. cholerae O1 LPS (250 ng/well), or GM1
ganglioside (100 ng/well) followed by recombinant CTB (50 ng/
well). Plates were incubated with diluted patient sera (1:50 for LPS
ELISA and 1:200 for CTB ELISA), washed, and horseradish
peroxidase-conjugated secondary antibodies to human IgG or IgA
(Jackson Laboratories, Bar Harbor, Maine) were applied in
separate wells. Plates were developed using 0.1% orthophenylene
diamine (Sigma, St. Louis, Missouri) in 0.1 M sodium citrate
buffer with 0.1% hydrogen peroxide, and optical densities (OD)
were read kinetically at 450 nm for 5 minutes at 19-s intervals and
results expressed as milliabsorbance/min (mAb/min). ELISA
values were calculated by taking the ratio of the value obtained
for the test specimen to that obtained for the positive control
specimen and multiplying by a factor of 100. Pooled plasma was
prepared using specimens from convalescent stage cholera patients
from an earlier study [29].
Statistical analyses
Statistical analyses were performed on SPSS 17.0 and
SigmaStat 3.1 programs. Graphs were prepared using the Prism
5.0 software (GraphPad Software Inc.). The association between
Lewis blood groups and symptomatic cholera was assessed by the
chi-square test. Associations were also carried out by calculating
the odds ratio (OR) with 95% confidence intervals (CI) using
EpiInfo 3.3.2. The Wilcoxon signed rank test was used to compare
immune responses of patients on different follow-up days and the
Mann-Whitney U test was used for comparison among different
groups. All reported P values are two tailed and significance was
defined as P,0.05.
Results
Demographic features and clinical outcomes of patients
and household contacts
Ninety five cholera patients, 144 household contacts, and 283
healthy controls were enrolled in the study overall (Table 1). The
median age of the patients enrolled in the study was 28 years while
that for the household contacts was 23 years and of healthy
controls was 18 years. The controls were younger than the patients
and healthy contacts (P,0.001). The proportion of males and
females in each group was not significantly different. Thirty five
household contacts had positive rectal swabs for V. cholerae O1
during follow up and of these, 20 had diarrhea and were
considered to have symptomatic cholera; these 20 were excluded
from the analysis of Lewis blood group types in contacts. Among
the index patients, 80% (76/95) were infected with the Ogawa
serotype of Vibrio cholerae O1 and 20% (19/95) were infected with
Vibrio cholerae O1 Inaba. At the time of hospitalization, 92% (87/
95) of the index patients were severely dehydrated. The average
duration of diarrhea for all index patients was 57 hours and
patients received on average 7.5 liters of intravenous rehydration.
Distribution of ABO blood group in the study
participants
Among the 95 index patients, 43% were blood group O
positive, 34% were blood group B, 19% were blood group A, and
4% were blood group AB. The asymptomatic contacts had a
similar distribution of ABO blood groups (47%, 27%, 18% and
8% respectively). We did not determine the ABO blood group of
individuals enrolled as healthy controls but this has been done in
earlier studies [12,46]. The distribution of ABO blood group in a
similar setting in Bangladesh has been shown to be for the
O:A:B:AB groups to be 28%:23%:38%:11% respectively [46].
Table 1. Demographic characteristics of study participants.
Variable Patients (n=95) Household contacts (n=144) Healthy Controls (n=283)
Median age (range) 28 (4–59 yr) 23 (3–60 yr) 18 (4–49 yr)
% Female 42 50 53
No. rectal swab positive 95 35 -
No. with severe dehydration 87 - -
doi:10.1371/journal.pntd.0001413.t001
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symptomatic cholera
In the 522 study participants overall, 28% were Le(a+b2), 55%
were Le(a–b+), and 17% were of the Le(a–b2) blood group
phenotype, very similar to the proportions shown in this
population previously [15]. In comparing the Lewis blood group
phenotype distributions between patients symptomatic with
cholera compared to asymptomatic household contacts and
healthy controls, patients were enriched for the Le(a+b2)
phenotype (39%) and had fewer individuals in the Le(a–b+)
phenotype (40%); both these were significantly different than the
frequencies of these phenotypes in asymptomatic contacts and
healthy controls (Figure 1). In contrast, the distribution of the three
phenotypes in asymptomatic contacts and healthy controls were
virtually identical to each other and to the overall population. The
Le(a+b2) blood group phenotype was significantly associated with
having symptomatic cholera, as compared to the household
contacts who were asymptomatic (OR 1.91, P=0.039, 95% CI
1.03–3.56) or to the healthy controls (OR 1.90, P=0.014, 95% CI
1.13–3.21). Similarly the frequency of Le(a–b+) was lower in
patients than the contacts (OR 0.45, P=0.006, 95% CI 0.25–0.81)
or healthy controls (OR 0.48, P=0.003, 95% CI 0.29–0.79). No
relationship was found between the presence of Le(a–b2) blood
group phenotype and susceptibility to cholera comparing the three
groups of study participants (Figure 1).
Association of cholera with Lewis blood group
phenotypes within individual ABO blood groups
We also analyzed the presence of different combinations of
Lewis blood group antigens and ABO blood groups in relation to
susceptibility to cholera (Figure 2). In individuals with the A blood
group, the Le(a–b+) phenotype was less common in patients than
household contacts (P=0.001), while the percentage of the
Le(a+b2) phenotype in patients trended toward being higher
than in contacts (P=0.071), as seen for the group overall.
Similarly, in individuals with blood group B, we found a lower
frequency of the Le(a–b+) phenotype in patients compared to
contacts (P=0.048), as for the analysis in the study population
overall. However, we did not find any significant associations of
Lewis blood group antigens and symptomatic cholera in patients
with blood group O. The small number of individuals with blood
group AB (n=14) prevented any firm conclusions for this blood
group.
Association of Lewis phenotypes with immunologic
responses to cholera in patients
We next assessed whether there were any differences in immune
responses to V. cholerae O1 infection in individuals with the various
Lewis blood group phenotypes. We found no differences in plasma
vibriocidal titers on days 2, 7, or 30 between index patients with
the different Lewis blood group phenotypes (data not shown). In
analyzing IgG and IgA responses to CTB and LPS, we also found
no differences in either IgG or IgA responses to CTB or the IgG
responses to LPS (Figure 3). However, patients with the Le(a–b2)
phenotype developed significantly lower LPS IgA responses on day
7 compared to the individuals with the Le(a–b+) phenotype
(P=0.034); there was a trend of lower responses when compared
to those of the Le(a+b2) phenotype (P=0.064). The responses in
patients in the different Lewis groups were comparable by day 30
(Figure 3A).
Association of Lewis blood group antigen with severity
of cholera in index patients
Because of the differences in IgA responses to LPS between
individuals with the different Lewis blood group antigens, we also
compared the severity of cholera in these three groups. There were
no differences between the groups in the time between onset of
symptoms and presentation to the icddr,b, in the duration of
diarrhea pre-hospitalization, in the use of antibiotics prior to
presentation, or in the average ORS consumed before presenta-
tion (data not shown). However, once hospitalized, patients with
the Le(a–b+) phenotype required significantly less intravenous
fluids compared to individuals with either the Le(a+b2)
(P=0.017) or Le (a–b2)( P ,0.001) phenotypes (Table 2). In
addition, patients with the Le(a–b2) phenotype had a significantly
longer duration of diarrhea than did the patients of Le(a–b+)o r
Le(a+b2) groups (P=0.012 and 0.017, respectively), correlating
with their increased need for intravenous hydration (Table 2).
Discussion
In this study, we investigated the relationship of the Lewis blood
group antigens with susceptibility to cholera and to the clinical
course of the illness. We determined the Lewis blood group using
saliva samples, which have been previously shown to be
concordant with typing carried out using blood specimens [20].
The overall ABO and Lewis blood group antigen distribution was
similar to that seen in other studies carried out recently in
Bangladesh [15,20].
Our first finding in this study was that individuals with the
Le(a+b2) phenotype were more likely to get symptomatic cholera
compared to the other two groups, suggesting that this Lewis blood
group may be associated with an increased risk of being colonized
with V. cholerae O1 or if colonized, of becoming symptomatic. This
same Lewis blood group has previously been shown to increase
susceptibility to symptomatic ETEC infection if the organism is
expressing a CFA/I group colonization factor [15,20]. Interest-
ingly, in looking at the inter-relationship between risk of
Figure 1. Association between Lewis blood group and
symptomatic cholera infection. Lewis blood group phenotype
was determined using dot blot immunoassay procedure from saliva
samples. The chi-square test was used to compare the distribution of
Lewis blood types in different populations, i.e. patients, contacts and
healthy controls.
doi:10.1371/journal.pntd.0001413.g001
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increased risk of symptomatic infection in Le(a+b2) individuals
was only seen in individuals who had the A or B blood groups, and
not blood group O. Since blood group O is itself a risk factor for
more severe cholera, it is possible that an effect of the Lewis blood
group types was not evident because of the higher risk of
symptoms already conferred by the O blood group. Our second
finding, that individuals with the Le(a–b+) phenotype required less
intravenous fluids following hospitalization than individuals of the
Le(a+b2) phenotype, is also consistent with a difference in severity
of cholera, once it occurs, between these two Lewis blood groups.
Our third finding was that individuals in the Le(a–b2)
phenotype admitted to the icddr,b with cholera required the most
intravenous fluids and had the longest duration of diarrhea,
suggesting that this phenotype, while not over-represented in
patients with cholera, was associated with an increased severity of
disease once it occurs. We observed that there was a trend of
susceptibility to cholera for those in the Le(a–b2) group also, but
possibly because of the small sample size, the analysis did not reach
statistical significance. The fourth finding in our study was that
individuals with the Le(a–b2) phenotype had reduced IgA
responses to LPS compared to individuals in the other two
phenotypes although comparison with Le(a+b2) did not reach
significance. The plasma level of IgA reactive to LPS on exposure
is correlated with protection from subsequent infection with V.
cholerae O1 [8]. Index patients in the different Lewis blood group
types did not have any significant differences in baseline IgA
reactive to LPS, just a difference in magnitude of response at day
7. It is not known if this reduced magnitude of LPS-specific IgA on
day 7 is associated with the longer duration of diarrhea and
therefore higher requirement for intravenous fluid in this subgroup
of individuals; the differences in LPS-specific IgA between groups
was not evident by day 30 post infection.
Histo-blood group antigens can predispose individuals to
genetic, metabolic, and infectious diseases, including enteric
illnesses. Blood group antigens are fucosyloligosaccharides that
are expressed in the gut epithelium and hence can act as potential
receptors for enteric pathogens [22,31]. This can make individuals
of one blood group type more susceptible to a particular pathogen
compared to individuals expressing other blood group antigens.
Another mechanism of association with disease is that soluble
forms of these antigens can be secreted into the gut lumen and
might prevent colonization of pathogens by competitive neutral-
ization [32]. Earlier studies have shown that individuals with Lewis
Figure 2. Association between ABO and Lewis blood group and cholera infection. Statistical analyses were done to determine the
relationship of cholera with Lewis blood group types in each ABO group phenotype individually.
doi:10.1371/journal.pntd.0001413.g002
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pylori [22,33]. Campylobacter jejuni binds to intestinal H (blood group
O) antigen and it has been shown that fucosyloligosaccharides in
human milk can inhibit binding and infection by this organism
[34]. Norovirus has been particularly well studied for the
association with blood group antigens. This pathogen binds
specifically to A, H and difucosylated Lewis antigens but not to the
B antigen [35], which is supportive of earlier studies in which it
was shown that individuals with O blood group were more prone
to Norovirus infection, while it was less likely in individuals of the
B blood group [36].
Susceptibility to V. cholerae infection is believed to result from a
combination of factors including exposure, lack of immunity on
encountering the organism [8,12], nutritional deficiencies [37,38],
and human genetic polymorphisms [11]. Individuals with blood
group O are at a higher risk of developing severe cholera than
those with other blood groups [12,13,14,39]. It is hypothesized
that this may have resulted in a selective pressure for human
genetic evolution that may explain the lower prevalence of the O
blood group in cholera endemic regions such as Bangladesh and
other areas near the Ganges delta [40]. In the present study, we
Figure 3. Association between Lewis blood group and immune responses following cholera. The Signed rank test was used to compare
antibody responses on different days. The Mann Whitney U test was used to compare immunologic responses in patients of different Lewis blood
groups. Asterisks indicate significantly higher responses at convalescence (day 7 and day 30) compared to that in acute stage (day 2), using a paired t-
test. Brackets denote statistically significant lower LPS-specific IgA responses on day 7 in patients with the Le(a–b2) phenotype compared to the
other two groups.
doi:10.1371/journal.pntd.0001413.g003
Table 2. Association of Lewis blood group with clinical
characteristics of hospitalized cholera patients.
Variable Lewis Phenotype
Number with severe dehydration Le(a+b2) 32/37
Le(a–b+) 37/38
Le(a–b2) 18/20
Average duration of diarrhea Le(a+b2)5 4 h r
Le(a–b+)5 3 h r
Le(a–b2)7 3 h r *
Average quantity of IV fluid required Le(a+b2) 8.3 L
Le(a–b+) 5.6 L*
Le(a–b2) 10.7 L
*Significantly different (P,0.05) from other groups by Rank sum test.
doi:10.1371/journal.pntd.0001413.t002
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ABO blood groups, perhaps related to our smaller sample size.
However, we did find a strong association with the Lewis blood
group phenotypes, although the reasons behind this observation
are not yet defined. Two possibilities are that, as for ETEC, the
Le
a antigen may act as a receptor on mucosal epithelia for a
cholera ligand. However, Le(a+b2) individuals are also non-
secretors, so it is possible that the association of this phenotype
with symptomatic cholera is intertwined with the non-secretor
status rather than the Le
a and Le
b antigens themselves.
In contrast to cholera, individuals with blood groups A and AB
are at higher risk for ETEC infection [15,41,42]. On the other
hand, for the Lewis blood group antigens, individuals with the
Le(a+b2) phenotype are more susceptible to both symptomatic
cholera as well as ETEC infection. The distribution of Lewis blood
group phenotypes in this study was different from that reported in a
Caucasian population in a cholera non-endemic area, but similar to
populations studied in India and Africa, where cholera is endemic
[19,43,44]. However, unlike the relationship between ABO blood
group and cholera, the Lewis blood group phenotypes have
apparently not been selected for by cholera, as the more susceptible
type, Le(a+b2), is more frequent in the endemic areas than in those
areas without endemic cholera [19,43,44]. Perhaps selective
pressure for the Lewis blood group antigens is weaker than for the
ABO blood group system, and the endemicity of choleraand ETEC
diarrhea in settings such as Bangladesh may be partially explained
by the increased presence of the Le(a+b2) phenotype.
Factors influencing susceptibility to cholera may also play a role
in responses to cholera vaccines. For example, in a large scale field
trial conducted in Matlab, Bangladesh of the role of ABO blood
group and efficacy of an oral, killed cholera vaccine, there was
substantially lower protection in recipients who were blood group
O [45]. We have also shown previously that in Bangladeshi
children receiving a live, oral attenuated cholera vaccine, Peru 15,
the frequency of serological responders was higher in children of
the A blood group compared to the O blood group [46]. Thus, the
ABO blood group system is a potential factor that may affect
vaccination efficacy in different settings, and this factor has now
been included in the assessment of ongoing cholera vaccine trials.
In the present study, we found that individuals who were negative
for both Lewis antigens ‘a’ and ‘b’ had impaired LPS-specific IgA
responses on day 7 compared to individuals with Le (a–b+) Lewis
antigen phenotypes. This suggests that inclusion of the Lewis
blood group should be considered in cholera vaccine efficacy trials
in the future as well as the ABO blood group types.
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